Review Article20 Feb 2024 Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations Benedict Stanberry Nikki Webber-Jones Review Article13 Mar 2024 Ejaculation sparing of classic and minimally invasive surgical treatmen...
Review Article07 Mar 2025 Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection In this Review, Bruhm et al. provide a comprehensive overview of targeted and genome-wide cell-free DNA detection approaches, examining their potential to complement existing screening programmes ...
Cancer Pathogenesis and Therapy《癌症发生与治疗(英文)》(CN10-1882/R, ISSN:2949-7132)于2023年1月30日创刊 (季刊,开放获取),是中华医学会主办,中华医学会杂志社出版的唯一一本肿瘤学领域国际化英文期刊,入选国家“2021年中国科技期刊卓越行动计划高起点新刊”项目。荣誉主编:中国工程院桑国卫院士;主编: 国家癌症...
Review articleAbstract only Unraveling UPR-mediated intercellular crosstalk: Implications for immunotherapy resistance mechanisms Si Lu, ... Yu-Xiong Feng 1 May 2025 Review articleOpen access Clinical development of immuno-oncology therapeutics Jianxin Wang, ... Lei Zheng ...
Featured Article: Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy The CRISPR system is a revolutionary genome editing tool that has the potential to revolutionize the field of cancer research and therapy. The ability to precisely target and...
Article publishing options Open Access Article Publishing Charge (APC):USD 4,960 (excluding taxes).The amount you pay may be reduced during submission if applicable. Reviewthis journal’s open access policy. Subscription No publication fee charged to authors, and published articles are immediately av...
Review articleOpen access Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysis Fabian Acker, ... Friederike C. Althoff ...
Treatment-changing news in urogenital cancer—abrief unstructured narrative review based on findings presented at the ESMO 2023 conferencedoi:10.1007/s12254-024-00964-yBladder cancerESMO 2023FGFRUrothelial cancerThis article gives an overview through the most promising and practise changing studies ...
Peer Review reports Background Breast cancer (BC) is the most common cancer among women and a leading cause of cancer-related deaths worldwide, accounting for approximately 11.6% of all cancer deaths [1, 2]. Neoadjuvant chemotherapy (NAC) has emerged as the standard treatment for stage II –...
Sections Figures References Abstract Introduction Results Discussion Methods Data availability Code availability References Acknowledgements Author information Ethics declarations Peer review Additional information Supplementary information Rights and permissions About this article Advertisement...